Podcast: BMS and Bird & Bird on doing major deals in a pandemic

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: BMS and Bird & Bird on doing major deals in a pandemic

Sponsored by

twobirds-400px.jpg
 L to R: Henry Hadad, James Baillieu, Sally Shorthose

Max Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work

In the last 10 months, we have all become accustomed to working remotely and doing things differently. For lawyers, one of the impacts has been on major deals, particularly those with a cross-jurisdictional focus.

In Managing IP’s latest podcast, panellists from Bristol Myers Squibb and Bird & Bird share their thoughts on whether efficiency has increased, if we have said goodbye to paper for good, and whether we are in a licensor or licensee market. 

To learn more about completing deals in a pandemic, and for a preview of the year ahead, check out our 40-minute podcast by clicking on the link above.

more from across site and SHARED ros bottom lb

More from across our site

In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
The court will hand down its ruling in Iconix v Dream Pairs on Tuesday, June 24, in a case that concerns post-sale confusion
Developments included a stay in a row concerning the UPC’s jurisdiction and a timeline for the rollout of the long-awaited new CMS
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Companies must conduct thorough IP due diligence – even if it may not be mandatory
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
A team of partners that joined Boies Schiller Flexner say they would like to double the firm’s patent litigation capabilities
Gift this article